Literature DB >> 2429069

Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides.

M Osborn, G van Lessen, K Weber, G Klöppel, M Altmannsberger.   

Abstract

Monoclonal antibodies which recognize particular keratin polypeptides have been used to analyze normal human tissues including pancreas, stomach, colon, gall bladder, and liver as well as tumors of the gastrointestinal tract by immunohistological techniques. Broad specificity (lu5), ker 8 (Troma 1) and ker 18 (CK2) antibodies were positive while a ker 14 specific antibody (CKB1) was negative on all specimens tested. Differential staining patterns were seen with a ker 7 (CK7) and a ker 19 (KA4) antibody. Both antibodies stained gall bladder epithelium, pancreatic ducts but not acinar cells, as well as pancreatic ductal adenocarcinomas. KA4 but not the CK7 antibody stained adenocarcinomas of the stomach and large bowel. Both antibodies stained bile ducts and cholangiocellular carcinoma of the liver but did not stain hepatocytes or hepatocellular carcinomas. The results with keratin monoclonal antibodies compare well with those obtained by others using two dimensional gel electrophoresis and they further support the idea that monoclonal antibodies specific for particular keratin polypeptides will find applications in routine pathological diagnosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429069

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

1.  Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis.

Authors:  M Murota; M Nishioka; J Fujita; N Dobashi; F Wu; Y Ohtsuki; S Hojo; J Takahara; S Kuriyama
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Mucinous nonneoplastic cyst of the pancreas: a truly novel pathological entity?

Authors:  Brian-Kp Goh; Yu-Meng Tan; Puay-Hoon Tan; London L P J Ooi
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

3.  Differential expression of N-CAM, vimentin and MAP1B during initial pathfinding of olfactory receptor neurons in the mouse embryo.

Authors:  K Aoki; N Osumi-Yamashita; Y Ninomiya; K Eto
Journal:  Anat Embryol (Berl)       Date:  1995-09

4.  The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells.

Authors:  E B van Dorst; G N van Muijen; S V Litvinov; G J Fleuren
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

5.  Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract.

Authors:  H E Schaafsma; F C Ramaekers; G N van Muijen; E C Ooms; D J Ruiter
Journal:  Histochemistry       Date:  1989

6.  Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient.

Authors:  P van Eyken; R Sciot; B van Damme; C de Wolf-Peeters; V J Desmet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice.

Authors:  F Gärtner; L David; R Seruca; J C Machado; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

Review 8.  A review of intermediate filament biology and their use in pathologic diagnosis.

Authors:  R B Nagle
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

9.  An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.

Authors:  Y Yang; S E Raper; J A Cohn; J F Engelhardt; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Authors:  T Uenishi; S Kubo; K Hirohashi; H Tanaka; T Shuto; T Yamamoto; S Nishiguchi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.